Back
Dynex Capital Vs. Novo Nordisk AS Industry Stock Comparison
Sell
47
DX
Dynex Capital
Last Price:
$12.58
Seasonality Move:
2.69%
Sell
13
NONOF
Novo Nordisk AS
Last Price:
$84.75
Seasonality Move:
6.94%
Sell
47
Dynex Capital (DX)
is a Sell
Is Dynex Capital a Buy, Sell or Hold?
-
The current Dynex Capital [DX] share price is $12.57. The Score for DX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
DX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
13
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
DX Stock Price Chart
What is Dynex Capital's stock price today?
-
The Dynex Capital share price today is $12.57Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DX is experiencing slight buying pressure.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $84.75Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
DX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 51.64 | Buy |
Chaikin Money Flow: | 944621 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.43 - 12.65) | Buy |
Bollinger Bands (100): | (12.24 - 12.64) | Buy |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.51 | Sell |
Relative Strength Index (14 RSI): | 24.55 | Sell |
Chaikin Money Flow: | 64911 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (100.57 - 111.43) | Sell |
Bollinger Bands (100): | (107.18 - 131.16) | Sell |
DX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.59 | Sell |
20-day SMA: | 12.56 | Buy |
50-day SMA: | 12.47 | Buy |
200-day SMA: | 12.28 | Buy |
8-day EMA: | 12.55 | Buy |
20-day EMA: | 12.55 | Buy |
50-day EMA: | 12.5 | Buy |
200-day EMA: | 12.35 | Buy |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 105.03 | Sell |
20-day SMA: | 106.85 | Sell |
50-day SMA: | 109.33 | Sell |
200-day SMA: | 126.14 | Sell |
8-day EMA: | 102.09 | Sell |
20-day EMA: | 105.65 | Sell |
50-day EMA: | 110.06 | Sell |
200-day EMA: | 118.01 | Sell |
Dynex Capital Earnings Growth & DX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $1.63 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
Dynex Capital Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |